In March 2025, the company declared new programs for any direct-to-shopper featuring of its Wegovy weight loss drug. The company recognized a different pharmacy, known as NovoCare, which would cost consumers $499 per 30 days for entry to the drug, a lot less than 50 percent the price of the drug through other pharmaceutical distribution networks.[5